These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25996576)

  • 21. Adaptive brachytherapy of cervical cancer, comparison of conventional point A and CT based individual treatment planning.
    Wanderås AD; Sundset M; Langdal I; Danielsen S; Frykholm G; Marthinsen AB
    Acta Oncol; 2012 Mar; 51(3):345-54. PubMed ID: 22035118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
    Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
    Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should the organs at risk be contoured in vaginal cuff brachytherapy?
    Holloway CL; Macklin EA; Cormack RA; Viswanathan AN
    Brachytherapy; 2011; 10(4):313-7. PubMed ID: 21193355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations.
    Lang S; Nulens A; Briot E; Kirisits C; De Brabandere M; Dumas I; Dimopoulos J; Petrow P; Georg D; Van Limbergen E; Haie-Meder C; Pötter R
    Radiother Oncol; 2006 Feb; 78(2):185-93. PubMed ID: 16466820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer.
    Dewitt KD; Hsu IC; Speight J; Weinberg VK; Lessard E; Pouliot J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1270-4. PubMed ID: 16253782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric comparison of (192)Ir high-dose-rate brachytherapy vs. 50 kV x-rays as techniques for breast intraoperative radiation therapy: conceptual development of image-guided intraoperative brachytherapy using a multilumen balloon applicator and in-room CT imaging.
    Jones R; Libby B; Showalter SL; Brenin DR; Wilson DD; Schroen A; Morris M; Reardon KA; Morrison J; Showalter TN
    Brachytherapy; 2014; 13(5):502-7. PubMed ID: 24933339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy.
    Dickler A; Kirk MC; Seif N; Griem K; Dowlatshahi K; Francescatti D; Abrams RA
    Brachytherapy; 2007; 6(2):164-8. PubMed ID: 17434111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between the ICRU rectal point and modern volumetric parameters in brachytherapy for locally advanced cervical cancer.
    Mazeron R; Kamsu Kom L; Rivin del Campo E; Dumas I; Farha G; Champoudry J; Chargari C; Martinetti F; Lefkopoulos D; Haie-Meder C
    Cancer Radiother; 2014 Jun; 18(3):177-82. PubMed ID: 24751222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interfraction physical dose variations in high-dose-rate brachytherapy for carcinoma cervix based on computed tomography image dataset to find the compatibility of the first fraction plan to treat successive fractions.
    Yadav S; Singh OP; Choudhary S; Saroj DK; Maurya AK; Yogi V
    J Cancer Res Ther; 2019; 15(6):1304-1308. PubMed ID: 31898664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
    Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
    Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications for dosimetric changes when introducing MR-guided brachytherapy for small volume cervix cancer: a comparison of CT and MR-based treatments in a single centre.
    Dempsey C; Govindarajulu G; Sridharan S; Capp A; O'Brien P
    Australas Phys Eng Sci Med; 2014 Dec; 37(4):705-12. PubMed ID: 25344886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric Considerations for Ytterbium-169, Selenium-75, and Iridium-192 Radioisotopes in High-Dose-Rate Endorectal Brachytherapy.
    Shoemaker T; Vuong T; Glickman H; Kaifi S; Famulari G; Enger SA
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):875-883. PubMed ID: 31330175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
    Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator.
    Hepel JT; Hiatt JR; Cardarelli GA; Wazer DE
    Brachytherapy; 2010; 9(1):81-5. PubMed ID: 19850533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inter-application variation of dose and spatial location of D(2cm(3)) volumes of OARs during MR image based cervix brachytherapy.
    Jamema SV; Mahantshetty U; Tanderup K; Malvankar D; Sharma S; Engineer R; Chopra S; Shrivastava SK; Deshpande DD
    Radiother Oncol; 2013 Apr; 107(1):58-62. PubMed ID: 23453543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes.
    Siavashpour Z; Aghamiri MR; Jaberi R; ZareAkha N; Manshadi HRD; Kirisits C; Sedaghat M
    J Appl Clin Med Phys; 2016 May; 17(3):5-13. PubMed ID: 27167253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.